Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
Samsung Biologics has disclosed that the Supreme Court (court of third instance) dismissed the prosecution’s appeal regarding alleged violations of accounting standards, rendering a not-guilty verdict.
📊 [Key Disclosure Details & Financial Figures]
- Disclosure Title: Result of Action Such as Prosecution Referral for Violation of Accounting Standards
- Action Result: Not Guilty (Appeal Dismissed)
- Main Details of Violation: No violation
- Jurisdictional Court: Supreme Court (3rd Instance)
- Judgment / Confirmation Date: July 17, 2025
- Future Countermeasures: The company has continuously taken various measures to enhance accounting transparency and plans to strengthen internal controls and monitoring mechanisms going forward.
- Other Important Details:
- This disclosure is made in accordance with the 3rd instance court ruling.
- As of the filing date, the official written judgment has not yet been received; a correction disclosure will be issued once the judgment is obtained.
- Re-disclosure will be made if further developments or finalized facts occur.
- Related Disclosures:
- Action Such as Prosecution Referral for Violation of Accounting Standards: Jul 12, 2018 / Nov 14, 2018 / Sep 04, 2020 / Feb 08, 2024 / Feb 10, 2025
- Result of Action Such as Prosecution Referral for Violation of Accounting Standards: Feb 05, 2024 / Feb 08, 2024 / Feb 03, 2025 / Feb 04, 2025
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Monitoring Supreme Court Appeal Dismissal and Upcoming Correction Disclosure
This disclosure provides notice of the not-guilty verdict resulting from the Supreme Court’s dismissal of the prosecution’s appeal regarding alleged accounting standard violations.
Reviewing the forthcoming correction disclosure to be filed once the company receives the official written judgment is essential.
Relevant details can be verified in subsequent official disclosures and periodic reports.
📢 Disclaimer & Source Notice
Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
